M. Apperloo

The impact of centralization of services on treatment delay in ovarian cancer: A study on process quality

H. Nijman, G. C. Niemeijer, H. Arts, 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure

C. Lambalk, H. Groen, D. Braat, 2008, Menopause.

Recurrence and survival after laparoscopy versus laparotomy without lymphadenectomy in early-stage endometrial cancer: Long-term outcomes of a randomised trial.

G. Lunter, P. V. van Kesteren, J. Huirne, 2021, Gynecologic oncology.

Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factors

H. V. van Doorn, R. Zweemer, J. Custers, 2022, Supportive Care in Cancer.

In the Mood for Sex: The Value of Androgens

W. W. Weijmar Schultz, A. Hoek, M. Apperloo, 2003, Journal of sex & marital therapy.

ORIGINAL RESEARCH—ENDOCRINOLOGY: Vaginal Application of Testosterone: A Study on Pharmacokinetics and the Sexual Response in Healthy Volunteers

J. Wouda, W. W. Weijmar Schultz, A. Hoek, 2006 .

Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.

H. V. van Doorn, R. Zweemer, J. Piek, 2021, Gynecologic oncology.

Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial.

A. Maas, H. V. van Doorn, R. Zweemer, 2021, JAMA oncology.

Assessment of ovarian teratoma and lymphadenopathy by 18F-FDG PET/CT.

H. Balink, James Collins, M. Apperloo, 2012, Clinical nuclear medicine.

Assessment of ovarian teratoma and lymphadenopathy by 18F-FDG PET/CT.

H. Balink, James Collins, M. Apperloo, 2012, Clinical nuclear medicine.